BMJ  2004;328:241-242 (31 January), doi:10.1136/bmj.328.7434.241

Editorial

Access to antiretroviral treatment in Africa

New resources and sustainable health systems are needed

The first 150 words of the full text of this article appear below.

The demand for people living with HIV and AIDS in Africa to access treatment cannot be ignored. At the same time the challenges to meeting this demand are many. They include the shortfalls in health services and lack of knowledge about treatment, making decisions about newer regimens, and the risk of resistance to antiretrovirals highlighted in the paper by Stevens et al (p 280). ^{1 2} The challenges also include ensuring uninterrupted drug supplies, laboratory capacities for CD4 monitoring, accessible voluntary counselling and testing, trained healthcare workers, and effective monitoring of resistance to antiretroviral drugs.³ A series of papers produced in 2003 through the southern African regional network on equity in health raised further concerns about measures to ensure fairness in the rationing of scarce treatment resources and the diversion of scarce resources from strained public health services into vertical treatment programmes.^4-8

The reasons for these challenges are not a . . . [Full text of this article]

Training and Research Support Centre, (rene@tarsc.org)

EQUINET, 47 Van Praagh Avenue, Milton Park, Harare, Zimbabwe

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Human health resources are key to HIV treatment in Africa

Ntambwe Malangu
BMJ 2006 333: 98. [Extract] [Full Text]

Antiretroviral therapy in Africa

Warren Stevens, Steve Kaye, and Tumani Corrah
BMJ 2004 328: 280-282. [Extract] [Full Text] [PDF]

Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials

Yazdan Yazdanpanah, Daouda Sissoko, Matthias Egger, Yves Mouton, Marcel Zwahlen, and Geneviève Chêne
BMJ 2004 328: 249. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Boulle, A, Ford, N (2008). Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?. Postgrad. Med. J. 84: 225-227 [Full text]  
• Boulle, A, Ford, N (2007). Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?. Sex. Transm. Infect. 83: 503-505 [Full text]  
• Seoane-Vazquez, E., Rodriguez-Monguio, R. (2007). Negotiating antiretroviral drug prices: the experience of the Andean countries. Health Policy Plan 22: 63-72 [Abstract] [Full text]  
• Malangu, N. (2006). Human health resources are key to HIV treatment in Africa. BMJ 333: 98-98 [Full text]  
• Egger, M., Boulle, A., Schechter, M., Miotti, P. (2005). Antiretroviral therapy in resource-poor settings: scaling up inequalities?. Int J Epidemiol 34: 509-512 [Full text]  
• Furber, A. S, Hodgson, I. J, Desclaux, A., Mukasa, D. S (2004). Barriers to better care for people with AIDS in developing countries. BMJ 329: 1281-1283 [Full text]  
• Fraser, H. S F, Jazayeri, D., Nevil, P., Karacaoglu, Y., Farmer, P. E, Lyon, E., Fawzi, M. K. C S., Leandre, F., Choi, S. S, Mukherjee, J. S (2004). An information system and medical record to support HIV treatment in rural Haiti. BMJ 329: 1142-1146 [Full text]